Diamyd Medical AB Stock Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.03B 10.87B 1.4B |
---|---|---|---|---|---|
Net income 2018 | 25M 265M 34.17M | Net income 2019 | 77M 815M 105M | EV / Sales 2018 | - |
Net cash position 2018 | 253M 2.68B 346M | Net cash position 2019 | 83.08M 880M 114M | EV / Sales 2019 | - |
P/E ratio 2018 |
28.3
x | P/E ratio 2019 |
13.3
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 68.13% |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |